WHO ICTRP trial
Liposomal bupivacaine vs ropivacaine for ultrasound-guided transversus abdominis…
ChiCTR2400091811 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2400091811 |
|---|---|
| Public title | Liposomal bupivacaine vs ropivacaine for ultrasound-guided transversus abdominis plane blocks in laparoscopic lower abdominal tumor resection: A prospective randomized trial |
| Scientific title | Liposomal bupivacaine vs ropivacaine for ultrasound-guided transversus abdominis plane blocks in laparoscopic lower abdominal tumor resection: A prospective randomized trial |
| Primary sponsor | Sun Yat-Sen University Cancer Center |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | lower abdominal tumor |
| Interventions | Bupivacaine liposome group:Ultrasound guided bilateral TAPB was performed with bupivacaine liposomes;Ropivacaine group:Bilateral ultrasound-guided TAPB was performed with ropivacaine |
| Registration date | Nov 4, 2024 |
| Target size | Bupivacaine liposome group:37;Ropivacaine group:37 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: